Scott Cormack
2013
In 2013, Scott Cormack earned a total compensation of $1.6M as President and Chief Executive Officer at OncoGenex Pharmaceuticals, a 3% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $207,843 |
|---|---|
| Option Awards | $324,065 |
| Salary | $503,719 |
| Stock Awards | $552,986 |
| Total | $1,588,613 |
Cormack received $553K in stock awards, accounting for 35% of the total pay in 2013.
Cormack also received $207.8K in non-equity incentive plan, $324.1K in option awards and $503.7K in salary.
Rankings
In 2013, Scott Cormack's compensation ranked 4,711th out of 12,286 executives tracked by ExecPay. In other words, Cormack earned more than 61.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,711 out of 12,286 | 62nd |
Division Manufacturing | 1,616 out of 4,612 | 65th |
Major group Chemicals And Allied Products | 468 out of 1,462 | 68th |
Industry group Drugs | 328 out of 1,156 | 72nd |
Industry In Vitro and In Vivo Diagnostic Substances | 16 out of 56 | 71st |
Source: SEC filing on April 24, 2014.
Cormack's colleagues
We found three more compensation records of executives who worked with Scott Cormack at OncoGenex Pharmaceuticals in 2013.